Teva
Teva collaborates on skin disease treatment, releases targets
Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo
Teva seeks startups to help solve global pharmaceutical challenges
Placing the focus on the therapist
Does a common heart attack pill help everyone? Studies disagree
Outrage as Teva charges $18,275 for generic drug in US
B "Teva Pharmaceutical's new generic version of the drug Syprine… will cost 28 times what Syprine cost in 2010. We have a crisis in drug prices in this country," Senator Bernie Sanders said.
Embattled Teva fined NIS 75m. for bribing foreign officials
This comes as the company is laying off thousands of workers in an effort to balance its books
Teva delays 33% of Jerusalem layoffs until 2019
The company making its first gesture, albeit a small one, to the workers and the Histadrut.
This week in Jerusalem: Life after Teva
A proposal was made that there should be an incentive to other firms in Jerusalem to absorb as many dismissed Teva employees as possible.
Teva’s collapse – Israel’s biotech recovery
Over the past two years, Teva lost $57b. of value, leaving it with a remaining market value of $19b. It owes about $35b.
Value of Israeli mergers and acquisitions deals drops in 2017
The average price of each transaction fell by about 38%, but there was a slight 9% in the number of transactions this year, up to 131 M&A deals.
Rivlin: Major local companies should stay in Israel
"Israel is poor in natural resources, but rich in human resources."
Jerusalem's Teva turmoil
There are some 1,780 Jerusalemites employed at the city’s two branches of Teva, which for decades has been one of the country’s greatest industrial success stories.
Economy minister: Teva should earn its tax breaks
Teva has received some NIS 22 billion in tax breaks and grants over the past decade, without any conditions regarding layoffs in return.
Grapevine: Begin prize winner
In the early years of the state, Teva raised money on the newly established Tel Aviv Stock Exchange.
